Literature DB >> 11696286

Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.

J P Achkar1, B Shen.   

Abstract

Surgical intervention is often required for patients with inflammatory bowel disease. Total proctocolectomy with ileal pouch-anal anastomosis is the surgical treatment of choice for patients with ulcerative colitis. The main long-term complication of this surgery is pouchitis, with 10-year cumulative incidence rates between 24% and 46%. For patients with Crohn's disease, postoperative recurrence is a significant problem, with clinical recurrence rates as high as 55% at 5 years and 76% at 15 years. Increasing evidence suggests that postoperative medical therapy has the potential to decrease the risk of postoperative Crohn's disease recurrence.

Entities:  

Mesh:

Year:  2001        PMID: 11696286     DOI: 10.1007/s11894-001-0069-5

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  49 in total

Review 1.  Corticosteroids for maintaining remission of Crohn's disease.

Authors:  A H Steinhart; K Ewe; A M Griffiths; R Modigliani; O O Thomsen
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Authors:  P Gionchetti; F Rizzello; A Venturi; P Brigidi; D Matteuzzi; G Bazzocchi; G Poggioli; M Miglioli; M Campieri
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

3.  Perforating and nonperforating Crohn's disease. An unpredictable guide to recurrence after surgery.

Authors:  P J McDonald; V W Fazio; R G Farmer; D G Jagelman; I C Lavery; W B Ruderman; K A Easley; P H Harper
Journal:  Dis Colon Rectum       Date:  1989-02       Impact factor: 4.585

4.  Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy.

Authors:  R D Hurst; M Molinari; T P Chung; M Rubin; F Michelassi
Journal:  Arch Surg       Date:  1996-05

5.  Smoking habits and recurrence in Crohn's disease.

Authors:  M Cottone; M Rosselli; A Orlando; L Oliva; A Puleo; M Cappello; M Traina; F Tonelli; L Pagliaro
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

6.  Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.

Authors:  P Gionchetti; F Rizzello; A Venturi; F Ugolini; M Rossi; P Brigidi; R Johansson; A Ferrieri; G Poggioli; M Campieri
Journal:  Aliment Pharmacol Ther       Date:  1999-06       Impact factor: 8.171

7.  Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis.

Authors:  B Shen; J P Achkar; B A Lashner; A H Ormsby; F H Remzi; C L Bevins; A Brzezinski; R E Petras; V W Fazio
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

8.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

9.  Prediction of early symptomatic recurrence after intestinal resection in Crohn's disease.

Authors:  T M Heimann; A J Greenstein; B Lewis; D Kaufman; D M Heimann; A H Aufses
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

10.  Risk factors for early postoperative recurrence of Crohn's disease.

Authors:  E Lautenbach; J A Berlin; G R Lichtenstein
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  5 in total

1.  Gastrointestinal endoscopy biopsy derived proteomic patterns predict indeterminate colitis into ulcerative colitis and Crohn's colitis.

Authors:  Billy Ray Ballard; Amosy Ephreim M'Koma
Journal:  World J Gastrointest Endosc       Date:  2015-06-25

2.  Restorative proctocolectomy for pediatric patients with ulcerative colitis.

Authors:  Minako Sako; Hideaki Kimura; Katsuhiko Arai; Kazutaka Koganei; Fumihiko Kito; Akira Sugita; Tsuneo Fukushima
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

3.  Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.

Authors:  Ingvar Bjarnason; Bu Hayee; Polychronis Pavlidis; Charlotte Kvasnovsky; Astrid Scalori; Guy Sisson; Annika Charlesworth; Hizbullah Shaikh; Einar Bjornsson; Michael A Heneghan
Journal:  EBioMedicine       Date:  2015-09-02       Impact factor: 8.143

4.  VEN-120, a Recombinant Human Lactoferrin, Promotes a Regulatory T Cell [Treg] Phenotype and Drives Resolution of Inflammation in Distinct Murine Models of Inflammatory Bowel Disease.

Authors:  Christopher F MacManus; Colm B Collins; Tom T Nguyen; Randall W Alfano; Paul Jedlicka; Edwin F de Zoeten
Journal:  J Crohns Colitis       Date:  2017-09-01       Impact factor: 9.071

5.  Vedolizumab in the treatment of Crohn's disease of the pouch.

Authors:  Freeha Khan; Xian-Hua Gao; Amandeep Singh; Jessica R Philpott; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2018-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.